Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lowe`s Companies Inc (LOW) vs Stryker Corporation (SYK) Price & Performance

Lowe`s Companies IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Lowe`s Companies Inc vs Stryker Corporation — how do they compare? Lowe`s Companies Inc trades at $186 (market cap $105.96B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Lowe`s Companies Inc and Stryker Corporation are close in size by market cap, and Lowe`s Companies Inc pays the higher dividend (2.65%). Which is the better fit depends on your goals — on Pluang, investors hold Lowe`s Companies Inc for 98 Days and Stryker Corporation for 21 Days on average.

LOWSYK
Market Cap
$105.96B$106.24B
Volume
4,039,5472,982,001
Sector
Consumer CyclicalHealth
52-Week High
$287.39$388.35
52-Week Low
$179.50$269.75
Typical Hold Time
98 Days21 Days
Enterprise Value
$144.81B$117.70B
Dividend Yield
2.65%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lowe`s Companies Inc

Lowe's (LOW) trades at $186.00, up 2.46% with recent earnings beats but faces bearish technical signals. The stock shows solid fundamentals with a P/E of 15.96 and net margin of 7.35%, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. Recent news highlights drone delivery innovation with DoorDash and Alphabet, while the home improvement sector faces macroeconomic headwinds.

Wall Street maintains a bullish consensus with a $244.09 price target (31 Buy, 19 Hold, 1 Sell), representing 31% upside potential. Key risks include housing market stagnation and competitive pressure from Home Depot. The negative shareholder equity position requires monitoring, but consistent dividend payments and operational cash flow strength provide stability.

Stryker Corporation

Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.

The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LOW
2% Buy98% Sell
Avg holding period · 98 Days
SYK

No sentiment data available yet.

Top news

Latest headlines on both assets

About Lowe`s Companies Inc

Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.

Read more on LOW →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →